Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
about
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.Differential function of STAT5 isoforms in head and neck cancer growth control.Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors.Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
P2860
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
@ast
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
@en
type
label
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
@ast
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
@en
prefLabel
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
@ast
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
@en
P2093
P2860
P356
P1433
P1476
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
@en
P2093
Nieborowska-Skorska M
Slupianek A
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203754
P407
P577
2000-08-01T00:00:00Z
P5875
P6179
1020112653